| |
1.
The Sardinian IDDM Study :1. Epidemiology
and geographical distribution of IDDM in
Sardinia during 1989 to 1994. M. Songini,
L. Bernardinelli, D. Clayton, C. Montomoli,
C. Pascutto, M. Ghislandi, D. Fadda, G.F.
Bottazzo, and The Sardinian IDDM Study Groups.
Diabetologia (1998) 41: 221-227
2.
Atkinson MA, MacLaren NK. Islet cell autoantigens
in insulin-dependent diabetes. J. Clin. Invest.,
22: 1608-1616, 1992
3.
Nepom GT. Immunogenetics and IDDM Diabetes
Rev., 1: 93, 1993
4.
Cavallo MG, Fava D, Monetini L, Barone
F, Pozzilli P. Cell mediated immune response
to beta casein in recent onset of insulin
dependent diabetes: implication for disease
pathogenesis. Lancet, 348: 926-928, 1996.
5.
Pozzilli P. Prevention of IDDM: where we
are now? Diabetes Metab. Rev., 12: 127-135,
1996.
6.
Pozzilli P, Browne PD, Kolb H and the Nicotinamide
Trialists. Meta-analisys of nicotinamide
treatment in patients with recent onset insulin
dependent diabetes. Diabetes Care, 19: 1357-1363,
1996.
7.
Buzzetti R, Nisticò L, Osborn JF,
Giovannini C, Chersi A, Sorremmo R. HLA DQA1
and DQB 1 gene polymorphisms in Type 1 diabetic
patients from central Italy and their use
for risk prediction. Diabetes, 42: 1173-1178,
1993.
8.
Luo DF, Buzzetti R, Rotter J, Maclaren NK,
Nisticò L, Giovannini C, Pozzilli
P, Thomson G, She JX. Confirmation of three
susceptibility genes to insulin-dependent
diabetes mellitus: IDDM4, IDDM5, IDDM8, Human
Molecular Genetics, 5: 693-698, 1996.
9.
Todd JA. Genetic control of autoimmunity
in Type 1 diabetes. Immunol. Today, 11: 122-
128, 1990.
|
|
